The Trader Harbor
  • Business
  • Politics
  • World News
  • Stocks
  • Business
  • Politics
  • World News
  • Stocks

The Trader Harbor

Politics

National Cancer Institute spends $218M per year on grants for ‘underrepresented’ groups: source

by admin February 24, 2025
February 24, 2025
National Cancer Institute spends $218M per year on grants for ‘underrepresented’ groups: source

A watchdog group focused on getting diversity, equity and inclusion (DEI) out of medicine found that the National Cancer Institute (NCI) is actively spending millions of grant dollars to boost the number of racial minorities in the cancer workforce. 

This funding, uncovered by the nonprofit watchdog Do No Harm, shows that $218 million in NCI grants for ‘underrepresented’ groups – mainly racial minorities – is actively dispersed by the NCI. Prior to President Donald Trump taking office, during the Biden administration, around 3% of the NCI’s total grant funding every year went to institutions so that they can hire more faculty members and scientists who are minorities, according to Do No Harm.

The revelation comes as Elon Musk’s DOGE puts a slew of funds related to DEI on the chopping block amid efforts to slim down government spending. Trump and fellow Republicans have pushed hard against DEI policies throughout the government in recent weeks, making the case that public programs should instead focus on meritocracy. 

Among the NCI’s DEI grants that remain active under Trump are two totaling more than $10.5 million, awarded to the Icahn School of Medicine at Mount Sinai. These grants support hiring initiatives aimed at ‘inclusive excellence’ and programs that promote advancing the careers of racial minorities.

One of the grant’s descriptions explicitly calls for the recruitment of 12 scientists from ‘underrepresented groups,’ while the other grant’s description includes, alongside its recruitment and hiring goals, a plan to ‘modify the Mount Sinai Health System Task Force To Address Racism Roadmap for Change with key strategies as the basis for an Icahn School of Medicine at Mount Sinai Roadmap for Inclusive Excellence.’ 

In a statement to Fox News Digital, Do No Harm Chairman Dr. Stanley Goldfarb said the NCI must ‘stop promoting a politically motivated DEI agenda.’

‘The National Cancer Institute has been taking advantage of taxpayers to push a DEI agenda on the medical field,’ Goldfarb said. ‘They dole out $218 million each year for grants prioritizing ‘underrepresented’ in medicine, which has generally been defined as anyone from a racial minority group, except Asian Americans. The National Cancer Institute should not be rewarding racial discrimination with taxpayer money. Racial discrimination has no place in medicine.’

Under former President Joe Biden, the NCI’s website was filled with statements and sources about programs tied to DEI, but, following Trump’s executive order demanding an end to DEI in the federal government, much of that has come down. Fox News Digital reached out to the NCI to question whether it had any plans to terminate any of its active grants promoting DEI hiring, but did not receive a response by press time. 

Fox News Digital also inquired about the sub-agency’s Equity Council, established in 2021 under Biden, but did not receive a response. The council is a steering committee for the NCI’s equity and inclusion efforts.

DOGE claims it has already addressed hundreds of millions of taxpayer dollars in DEI-related contract cuts, including $350 million at the Department of Education. 

Last month, DOGE announced that taxpayers would see just over $1 billion in savings through the elimination of 104 DEI contracts.

This post appeared first on FOX NEWS

0
FacebookTwitterGoogle +Pinterest
previous post
‘Escape poverty’: Millions more food stamp recipients required to work under new House GOP proposal
next post
Trump announces Dan Bongino will be deputy director of the FBI

Related Posts

Bulk of truckers back Trump and are wary...

October 31, 2024

Sullivan rips reporter’s question on Biden swearing as...

March 19, 2024

President-elect Trump’s Syria dilemma: Intervene or let it...

December 23, 2024

Michelle Obama portraitist’s exhibit with trans Statue of...

July 26, 2025

Trump says he’s ‘not happy’ with Putin after...

May 26, 2025

Republicans fixated on Epstein are getting ‘duped’ by...

July 17, 2025

Trump’s Gaza relocation proposal sparks heated debate among...

February 11, 2025

Here’s what too many federal agencies don’t understand...

June 28, 2024

Trump administration prevails as appeals court pauses lower...

June 11, 2025

Johnson erupts over ‘dangerous’ Biden ‘cover-up’ as Democrats...

July 24, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • Bed Bath & Beyond relaunches with first store in Nashville, plans dozens more

      August 10, 2025
    • The Real Drivers of This Market: AI, Semis & Robotics

      August 10, 2025
    • S&P 500 Breaking Out Again: What This Means for Your Portfolio

      August 10, 2025
    • Sydney Sweeney jeans controversy making advertising great again

      August 10, 2025
    • Nagasaki mayor issues chilling warning on 80th anniversary of atomic bombing

      August 10, 2025
    • Kash Patel celebrates major FBI achievements and record seizures during Trump’s first 200 days in office

      August 10, 2025

    Categories

    • Business (1,330)
    • Politics (4,206)
    • Stocks (1,577)
    • Uncategorized (45)
    • World News (1,323)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheTraderHarbor, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 thetraderharbor.com | All Rights Reserved